FI960333A - Tryptaasi-inhibiittori - Google Patents

Tryptaasi-inhibiittori Download PDF

Info

Publication number
FI960333A
FI960333A FI960333A FI960333A FI960333A FI 960333 A FI960333 A FI 960333A FI 960333 A FI960333 A FI 960333A FI 960333 A FI960333 A FI 960333A FI 960333 A FI960333 A FI 960333A
Authority
FI
Finland
Prior art keywords
pct
novel
sec
date
vectors
Prior art date
Application number
FI960333A
Other languages
English (en)
Swedish (sv)
Other versions
FI960333A0 (fi
Inventor
Hans Fritz
Christian P Sommerhoff
Original Assignee
Ucp Gen Pharma Ag
Ciba Geigy Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ucp Gen Pharma Ag, Ciba Geigy Ag filed Critical Ucp Gen Pharma Ag
Publication of FI960333A0 publication Critical patent/FI960333A0/fi
Publication of FI960333A publication Critical patent/FI960333A/fi

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/81Protease inhibitors
    • C07K14/8107Endopeptidase (E.C. 3.4.21-99) inhibitors
    • C07K14/811Serine protease (E.C. 3.4.21) inhibitors
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/63Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/80Vectors or expression systems specially adapted for eukaryotic hosts for fungi
    • C12N15/81Vectors or expression systems specially adapted for eukaryotic hosts for fungi for yeasts
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biophysics (AREA)
  • Mycology (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Physics & Mathematics (AREA)
  • Plant Pathology (AREA)
  • Microbiology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Pulmonology (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Compounds Of Unknown Constitution (AREA)
  • Medicinal Preparation (AREA)
FI960333A 1993-07-26 1996-01-24 Tryptaasi-inhibiittori FI960333A (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP93111930 1993-07-26
PCT/EP1994/002445 WO1995003333A2 (en) 1993-07-26 1994-07-25 Tryptase inhibitor

Publications (2)

Publication Number Publication Date
FI960333A0 FI960333A0 (fi) 1996-01-24
FI960333A true FI960333A (fi) 1996-01-24

Family

ID=8213112

Family Applications (1)

Application Number Title Priority Date Filing Date
FI960333A FI960333A (fi) 1993-07-26 1996-01-24 Tryptaasi-inhibiittori

Country Status (13)

Country Link
US (1) US5972698A (fi)
EP (1) EP0714408B1 (fi)
JP (1) JPH09500532A (fi)
AT (1) ATE245660T1 (fi)
AU (1) AU694444B2 (fi)
CA (1) CA2164221A1 (fi)
DE (1) DE69432975T2 (fi)
FI (1) FI960333A (fi)
NO (1) NO960325L (fi)
NZ (1) NZ271635A (fi)
SG (1) SG52658A1 (fi)
TW (1) TW492975B (fi)
WO (1) WO1995003333A2 (fi)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2246498T3 (es) * 1995-11-13 2006-02-16 Vitaleech Bioscience N.V. Aislados antivirales obtenidos de sanguijuelas.
WO1997022626A1 (en) * 1995-12-15 1997-06-26 Novartis Ag Ldti crystals
GB9916913D0 (en) * 1999-07-19 1999-09-22 Natural Enviromental Research Inhibitor proteins
WO2006032436A2 (en) 2004-09-21 2006-03-30 Nascacell Technologies Ag. Use of microproteins as tryptase inhibitors
CN108017693A (zh) * 2017-12-14 2018-05-11 中国科学院昆明动物研究所 一种抗凝肽syap-1及其突变体和包括抗凝肽和/或突变体的抑制剂

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU560584B2 (en) * 1983-07-28 1987-04-09 Bayer Aktiengesellschaft Homologues of aprotinin
US4666829A (en) * 1985-05-15 1987-05-19 University Of California Polypeptide marker for Alzheimer's disease and its use for diagnosis
JPS6351335A (ja) * 1986-08-20 1988-03-04 Fuji Oil Co Ltd 肥満細胞脱顆粒抑制剤
US5187153A (en) * 1986-11-17 1993-02-16 Scios Nova Inc. Methods of treatment using Alzheimer's amyloid polypeptide derivatives
US4912206A (en) * 1987-02-26 1990-03-27 The United States Of America As Represented By The Department Of Health And Human Services CDNA clone encoding brain amyloid of alzheimer's disease
JPH01110697A (ja) * 1987-07-03 1989-04-27 Taisho Pharmaceut Co Ltd 新規プロテアーゼ阻害物質
DE58907373D1 (de) * 1988-03-07 1994-05-11 Ciba Geigy Modifizierte Proteine.
NZ231658A (en) * 1988-12-12 1992-05-26 Fmc Corp Inhibitors of protoporphyrinogen oxidase and compositions for killing tumour cells
KR920700287A (ko) * 1989-02-22 1992-02-19 사와무라 하루오 신규의 프로테아제 억제물질 및 그것의 제조방법
IL98405A0 (en) * 1990-06-11 1992-07-15 Fmc Corp Pharmaceutical compositions containing enzyme inhibiting agents

Also Published As

Publication number Publication date
EP0714408B1 (en) 2003-07-23
AU7532494A (en) 1995-02-20
US5972698A (en) 1999-10-26
AU694444B2 (en) 1998-07-23
TW492975B (en) 2002-07-01
WO1995003333A2 (en) 1995-02-02
FI960333A0 (fi) 1996-01-24
WO1995003333A3 (en) 1995-03-23
JPH09500532A (ja) 1997-01-21
NO960325D0 (no) 1996-01-26
EP0714408A1 (en) 1996-06-05
NZ271635A (en) 1998-04-27
CA2164221A1 (en) 1995-02-02
DE69432975T2 (de) 2004-05-06
ATE245660T1 (de) 2003-08-15
SG52658A1 (en) 1998-09-28
DE69432975D1 (en) 2003-08-28
NO960325L (no) 1996-01-26

Similar Documents

Publication Publication Date Title
BR9406689A (pt) Adenovirus recombinante defectivo utilização deste adenovirus e composição farmacêutica obtida
NO20006717L (no) Proteaseinhibitorer
ZA963593B (en) IL-6 activity inhibitor
NO972538L (no) Nye sulfonamider
DE69738581D1 (de) Menschliche dnase i hyperaktive varianten
TW279166B (fi)
KR960701051A (ko) 이미다조피리딘 및 이를 위장 질환의 치료에 사용하는 방법(imidazopyridines and their use in treating castrointestinal diseases)
NO962388L (no) Polyolblandinger og deres anvendelse ved fremstilling av höyelastiske polyuretanskum
PT716611E (pt) Metodo para reduzir a lesao do miocardio durante um enfarte do miocardio agudo
FI960333A0 (fi) Tryptaasi-inhibiittori
ATE332379T1 (de) Menschliche dnase resistent gegen actininhibitoren
HUT70215A (en) Thrombin inhibitors
DE59206628D1 (en) Expression signalpeptid-freier staphylokinasen
NO961357L (no) Nye terapeutisk aktive peptidforbindelser i blodkoagulasjonskaskaden, fremgangsmåte ved deres fremstilling og farmasöytiske sammensetninger inneholdende dem
DE69529235D1 (de) Menschliche dnase i varianten
HU9601298D0 (en) Endothelin-converting enzyme
WO2002096938A3 (en) Human kunitz-type protease inhibitor

Legal Events

Date Code Title Description
GB Transfer or assigment of application

Owner name: UCP GEN-PHARMA AG